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Abstract: 
In what is a global record time of getting the COVID-19 vaccines available within 11 months, the world has 
equally been faced with several myths and conspiracy theories dissuading the public from accepting vaccination 
as an important measure in the response to the pandemic. We reviewed the leading conspiracy theories and 
balanced these with the scientific basis of viral transmission and replication and the broad role of vaccination in 
tackling this challenge. We briefly examined the design of the leading vaccines, and provided recommendations 
for worldwide COVID-19 distribution, acceptance and use.  
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Abstrait: 
Dans ce qui est un temps record mondial pour obtenir les vaccins COVID-19 disponibles en 11 mois, le monde a 
également été confronté à plusieurs mythes et théories du complot dissuadant le public d'accepter la vaccination 
comme une mesure importante dans la réponse à la pandémie. Nous avons passé en revue les principales théories 
du complot et les avons équilibrées avec la base scientifique de la transmission et de la réplication virales et le 
rôle général de la vaccination dans la lutte contre ce défi. Nous avons brièvement examiné la conception des 
principaux vaccins et formulé des recommandations pour la distribution, l'acceptation et l'utilisation du COVID-
19 dans le monde. 
Mots clés: COVID-19, vaccin, anti-vaxxer, revue 
Introduction: 
 
 ‘The world hates change, yet it is the 
only thing that has brought progress’ (1). 
‘Progress is impossible without change, and 
those who cannot change their minds, cannot 
change anything’ (2). In 1882, the intro- 
duction of electricity was rejected. Several 
decades after Edison had formed the Edison 
Electric Illuminating Company of New York, 
most Americans still used gas lights and 
candles. In year 2020, anti-vaxxers are also 
doubting the science of the COVID vaccine and 
sponsoring theories to discredit its use. The 
social media is brimming with the unscientific 
personal opinions of a few political, commu- 
nity, and religious leaders asking their follo- 
wers to reject the COVID-19 vaccine. One of 
the consequences of rejection of the efforts of 
researchers and drug-makers in terms of 
public health is the slowdown of coronavirus 
vaccination campaigns in countries where 
these false claims are deeply rooted.  
 This indirect effect of anti-vaxxers’ 




influence may therefore weigh on mortality 
from coronavirus globally. This has apparently 
also downplayed the highly commendable feat 
accomplished in getting COVID-19 vaccines 
available within a record time of 11 months 
from when the first genome sequence of 
SARS-CoV-2 was made public and the emer- 
gence of the vaccines in December 2020. In 
this review, we briefly examined common 
conspiracy theories, and the design of the 
leading vaccines, and provided recommen- 
dations for acceptable worldwide COVID-19 
vaccines distribution and use. 
 
Common COVID-19 conspiracy/ 
anti-vaxxer theories 
 
Pfizer/BioNTech and Moderna mRNA vaccines 
will alter human DNA 
 This theory is untrue. The messenger 
RNA (mRNA) vaccines cannot change human 
DNA as this is located and tucked away inside 
the nucleus. The nucleus is a small rounded 
area found close to the centre of human cells, 
with the cytoplasm in the periphery (Fig 1). 
  
  Fig 1: Human cell  
 To transport the vaccines into the 
cytoplasm, mRNA is enveloped in smart lipid-
made layers called nanoparticles, where the 
mRNA is translated to spike proteins by a 
process known as ribosome processing (Fig 2).  
 
Fig 2: Virus vector DNA and mRNA vaccines’ ribosome 
processing in cells after vaccination 
This subsequently results in the SARS-COV-2 
antigen presentation for the body’s immune 
system to respond by making antibodies 
against the spike proteins needed to ward off 
future infections with COVID-19 virus after 
creating a T cell memory immune response. 
Therefore, the mRNA molecules cannot 
penetrate the nucleus to reach the DNA and 
alter it as widely acclaimed by the social media 
conspiracy theorists. It is also not possible for 
these mRNA vaccines to integrate into the host 
genome (3).  
New vaccine’s DNA would form chimers 
 Conspiracy theorists believe that the 
new vaccine causes a mixture between animal 
and viral DNA and the human DNA to form a 
chimera i. e. a single organism having cells 
with more than one genotype. In the real 
sense, the human DNA is already a natural 
form of chimera which is made of DNA of 
endogenous retroviruses and other inherent 
animal species. Thus, no new chimera is 
formed after the vaccine is given to a person. 
Vaccines created to reduce Africa’s population 
 This is particularly a major issue 
among people of African descent in general.  
In 2021, there is a higher level of ethical 
requirements and transparency about human 
subjects in clinical trials, drug safety policies, 
and vaccine formulation processes before they 
are used for disease prevention among the 
general public. The conspiracy theory which 
suggests that the newly approved COVID-19 
vaccines have been created to decimate the 
Africa’s population is not true. What is true is 
the fact that neither Pfizer plant which are 
located in Puurs, Belgium, or Michigan in the 
US nor the Lonza Moderna’s factory plant in 
the Swiss Alps have been primed to make a 
segregated vaccine for Africa alone.  
 What is needed to complement the 
use of the current vaccines would be for 
researchers in Africa to gather scientific data 
through polymerase chain reaction (PCR) 
assays, genomics, and antibody tests, to tell 
the African’s story about COVID-19. Such 
objectivity would lay the premise for evidence-
based vaccine protocols that would attests to 
the required dose and timing of vaccination to 
achieve herd immunity peculiar to Africa. 
Metals and toxins in vaccines are capable of 
human 5G radiation susceptibility               
 The ingredients in the vaccines as 
listed by the manufacturers show no metallic 
contents that could be toxins or cause human 
to be susceptible to 5G radiations. The only 
metals in vaccines are found in the buffer salts 
with neutral charges in salt, their quantities 
are too inconsequential to mount such false 
claim effects. 




Religious theories   
 A number of Christians view the Bill 
and Melinda Gates patent 060606 as the 
technology carrying the microchips that will 
also emblem the lipid nanoparticles in the 
COVID-19 vaccines. It is believed that the 
recipients of the COVID-19 vaccine potentially 
have the mark of the anti-Christ that will be 
used as cryptocurrency for the future. From 
scientific point of view, the nanoparticles used 
in the preparation of vaccines definitely do not 
carry microchips.    
 Nanoparticles are mere carriers or 
vehicles to convey and protect the genetic 
information as they travel to the target cells 
(6). Several other medications use nano- 
particles technology right now and their use 
will increase more because of their effective- 
ness in delivery medications to targeted sites 
without collateral damages to unrelated sites 
or organs (7-9).  
 Ionizable cationic lipids, phospho- 
lipids, cholesterol, and polyethylene glycol 
(PEG)-lipids are the main constituents of lipid 
nanoparticles (LNP) (Fig 3). Each component 
is responsible for payload protection, and 
enables effective intracellular delivery. Ioniz- 
able cationic lipids are fundamental drivers for 
nucleic acid entrapment, and determine the 
potency for intracellular delivery (10).  
 Nanoparticles may be referred to as 
smart-nanoparticles but they cannot be 
considered as microchips. In the Pfizer and 
Moderna vaccines, these nanoparticles are 
composed of lipids, most of them originally 
present in human cytoplasmic membranes and 
are serving as carriers to merely transport 
mRNA in the case of COVID-19 vaccines to 
target cells cytoplasm (11).
     
Box 1:  Vaccine contents 
 
Pfizer covid-19 vaccine: “Each dose has mRNA, lipids (4-hydroxybutyl) azanediyl) bis (hexane-6, 1-diyl) bis 
(2-hexyldecanoate), 2 [(polyethylene glycol)-2000]-N, N-ditetradecylacetamide, 1, 2-Distearoyl-sn-glycero-3-
phosphocholine, and cholesterol), potassium chloride, monobasic potassium phosphate, sodium chloride, dibasic 
sodium phosphate dihydrate, and sucrose” (4). 
 
Moderna COVID-19 vaccine: “Each dose has a total lipid content of 1.93 mg (SM-102, polyethylene glycol 
[PEG] 2000 dimyristoyl glycerol [DMG], cholesterol, and 1,2-distearoyl-sn-glycero-3-phosphocholine [DSP C]), 
0.31 mg tromethamine, 1.18 mg tromethamine hydrochloride, 0.043 mg acetic acid, 0.12 mg sodium acetate, 
and 43.5 mg sucrose” (5).  
 
 
Fig 3: Structure and Internal morphology of lipid nanoparticles containing siRNA 
 




 Meanwhile, some Muslims believe 
vaccines could be a form of ‘halal’ because of 
their usefulness in protecting humans from 
serious infections and diseases (12). Further- 
more, because some of these vaccines are 
made from components that were originally 
‘halal’, Pfizer and Moderna vaccines could be 
named ‘halal vaccines’ if declared to be so, 
based on fatwa i. e. a ruling on a point of 
Islamic law given by a recognized authority. 
Malaysia is currently conducting such a ruling 
on the COVID-19 vaccines.   
 Many scriptural references are in 
support of medicinal approaches to preventing 
and curing diseases or sicknesses (13). For 
example, Biblical and Hebrew healings have 
some of their bases and roots in natural 
elements such as balm, earth (dirt), oil, and 
salt. 
Luciferase technology use on COVID-19 
vaccinated persons   
 Infrared scanners and Luciferase 
technology are typically used to verify if an 
individual has had previous measles vaccina- 
tion. It is based on ability to exhibit bio- 
luminescence. There is no evidence to support 
that the current COVID-19 vaccines exhibit 
such bioluminescence technology. No approval 
has been granted to use luciferase technology 
on COVID-19 vaccinated patients. What is 
being advocated is a COVID-19 vaccine pass- 
port for travel and other verification purposes. 
COVID-19 vaccines 
 Traditionally, whole pathogen vaccine 
contains the virus or bacteria that cause the 
disease in a subdued form. Measles vaccine for 
example contains measles virus, and Hib 
vaccine contains Haemophilus influenza type b 
bacteria. There are two ways to make whole 
pathogen vaccines; the microbes are either 
deactivated (weakened) or exterminated 
(killed) to the point that they cannot make a 
person receiving the vaccine sick.  
 Vaccines work by stimulating the 
immune system to produce antibodies, exactly 
like it would if exposed to the disease-causing 
pathogen. After being vaccinated, the indivi- 
dual is expected to develop immunity to that 
disease such that should the vaccinated 
individual be exposed to the disease again, 
s/he would not suffer severe disease. The 
current COVID-19 vaccines in addition to this 
traditional approach utilised nucleic acid, viral 
vector, protein-based approaches to make 
current candidate vaccines. 
Pfizer-BioNTech vaccine  
 The vaccines from Pfizer and Moderna 
both work in the same way. The two vaccines 
use the tiny snippets of human genetic code, 
called mRNA, to prompt the immune system 
into producing antibodies to the coronavirus. 
These are the first such vaccines to be 
authorized for use. 
Moderna vaccine   
 Moderna vaccines like Pfizer-BioNTech 
are made from nucleic acids (mRNA) that are 
encapsulated into lipid nanoparticles prepared 
from mainly phospholipids and cholesterol. 
The synthetic phospholipids used in the 
process resemble the natural phospholipids 
found in the human cells. 
Oxford/AstraZeneca vaccine  
 The Oxford/AstraZeneca vaccine is 
another coronavirus vaccine, but differs in its 
preparation when compared with the Pfizer 
and Moderna vaccines. The Oxford/Astra- 
Zeneca vaccine has its roots in the adeno- 
virus-5, a virus taken from Chimpanzee. 
During the vaccine formulation, the adeno- 
virus-5 in a virus vector capsid is genetically 
modified to transport genetic information in 
form of virus DNA to the human cells for the 
subsequent translation to produce spike 
proteins (Fig 2). Spike proteins are the distin- 
guishing feature of the corona virus. Upon 
vaccination, it is expected that the human cells 
will start to produce the spike proteins and the 
spike proteins will lead to the generation of 
antibodies against these spike proteins to 
confer immunity against the coronavirus. 
Efficacy of the approved vaccines 
 As emergency use authorization (EUA) 
approvals continue to roll out throughout the 
world, the United Kingdom, Bahrain, Mexico, 
Saudi Arabia were trail blazers granting early 
authorizations for the use of the Pfizer 
BioNTech COVID-19 vaccine in their countries. 
Moderna vaccine was first granted emergency 
use authorization (EUA) in the United States. 
The first shot of the Moderna vaccine confers 
50% protection against the risk of developing 
severe COVID-19. The second dose, scheduled 
to be taken 28 days later, increases vaccine 
effectiveness to 94.1%. The Pfizer BioNTech 
COVID-19 vaccine first shot confers 52% 
protection against mild to severe disease, with 
the second dose taken after 21 days, offering 
up to 95% effectiveness (17). 
  




Box 2: Development of mRNA vaccines  
Messenger RNA (mRNA) was discovered and announced with fun fare as the foundation towards new vaccines 
and drugs development in 1961. For decades, the efforts and contributions mRNA therapeutics by Katalin Karikó, 
a biochemist at the University of Pennsylvania was not given its due regards (14). Adjunct Associate Professor 
Karikó researched extensively the technology to use mRNA as life’s building block in creating a new set of 
therapeutic agents in form of vaccines and drugs for unmet clinical needs. Karikó was one of the first to 
understand the concept of using mRNA molecules copy instructions from DNA in the cell nucleus, and transport 
them to the cytoplasm for ribosome processing to make vital therapeutic proteins. 
Nanoparticles-driven vaccine development process 
In a Petri dish, artificial mRNAs are made and transported in nanoparticles to cytoplasm’ ribosomes of human 
cells to make therapeutic proteins, corona spike proteins in the case of COVID-19 vaccines. These proteins 
presented as antigens to our immune system to generate specific antibodies to fight off a future exposure to the 
same virus should the vaccinated person become exposed again to the virus. 
Emergence of PCR  
In 1984, the polymerase chain reaction (PCR), was invented by the American biochemist, Kary Mullis (15). PCR 
was designed to amplify very small amounts of DNA, thus in vast use in genetics, genomics, crimes investigation 
etc. Few years down the lane, other life science researchers joined the train of creating catalytic actions of RNA 
polymerase enzyme to create mRNA molecules, thus generating mRNA from PCR by amplifying and multiplying 
DNA strands.  
Fatal immune response obstacle                     
For years, studies on use of the artificial mRNA stopped because of the severe inflammatory reactions on the test 
animals. To overcome this obstacle, Karikó collaborated with Drew Weissman, a respected immunologist (now a 
Professor of Infectious Diseases in Penn’s Perelman School of Medicine). They forged ahead when they created a 
form of mRNA incapable of provoking the immune system after Karikó discovered that uridine of the RNA’s genetic 
code could trigger certain immune receptors likely causing the fatal immune response.  
The success of 2005 led to today’s mRNA vaccines 
In 2005, Karikó and Weissman published a study replacing uridine to generate a specifically modified form of 
mRNA, which led to a non-fatal immune response (16). More extensive studies with the mice injected with this 
modified mRNA revealed a non-fatal immune response as the mice in the study survived. In 2010, Derrick Rossi 
co-founded a biotech company called Moderna, with the goal of this using modified mRNA to create vaccines and 
therapeutics on the premise of the study published by Karikó and Weissman. Using this technology, Moderna 
initially developed a potential Zika and Influenza vaccines. Therefore, when COVID-19 emerged, the company 
rode on this success story to develop their versions of COVID-19 mRNA vaccines.  In 2020 these mRNA-based 
vaccines; Moderna’s showed 94% efficacy, while Pfizer-BioNTech revealed 95% efficacy in a Phase III clinical 
trial. 
 
Side effects or adverse events 
post-vaccination 
 In clinical use round the world, the 
common side effects reported post vaccination 
typically are fever, injection site redness and 
pain. Others are itching, diarrhoea, vomiting, 
lethargy, muscle aches, headache, vertigo, 
and dizziness. These symptoms are usually 
worse after second dose and during the last 
few days. Pfizer BioNTech, Moderna, Astra- 
Zeneca have put in place post-vaccination 
pharmacovigilance and other safety surveil- 
lance systems in their bid to monitor the 
potential reactions that people might develop 
after taking these vaccines.  
 In the post-approval vaccination with 
Pfizer BioNTech vaccine, a few health workers 
in the UK were reported to have developed 
anaphylaxis. Anaphylactic reactions to vacci- 
nations usually occur in people with pre-
existing allergies or multiple allergies to any or 
all of the ingredients used in preparing the 
vaccines. In the light of this, the recommen- 
dation is for individuals prior to receiving 
vaccinations to answer all allergy questions 
truthfully. Users are expected to check the 
lists of ingredients in the vaccine and do not 
proceed if any known allergy is stated. It is 
recommended that individuals with multiple 
allergies are cautious while considering taking 
the Pfizer/ BioNTech vaccination.  
 The COVID-19 vaccines would be 
reviewed in due course to correctly ascertain 
if it poses some risks of birth defects to 
expectant mothers because the trials did not 
include pregnant or lactating women. It is 
worthy to note that according to UK gov.uk 
website (18), the safety and efficacy of the 
COVID-19 mRNA vaccine BNT162b2 in 
children under 16 years of age have not yet 
been established.  
Importance of T-cell tests post-
vaccination  
 T-cells originate from stem cells in the 
bone marrow. As they develop, they migrate 
to the thymus gland, hence their name "T" 
cells. In the thymus, they display antigens 
that are eliminated down to those that 
recognize self. Antigens distinguish subtypes;  




CD4+ T cells (helper T cell) recognize foreign 
antigens on macrophages, stimulate B cells to 
produce antibodies, secrete cytokines, and 
activate CD8+ T cells (cytotoxic T lymphocytes 
or CTLs). CD8+ T functions to burst virally-
infected cells.     
 In COVID-19, T cells appear a day or 
two after symptoms start; they bind the virus 
at several sites, and persist. Tracking CD8+ T 
cells in recovered COVID-19 patients or post 
vaccination of individuals using investigative 
longitudinal studies, can help to ascertain if 
memory CD8+ T cell response is sustained for 
an extended period. This would help to 
ascertain whether the current 6 months dosing 
vaccination regimen should be sustained long 
term.      
 A cohort study (19) revealed that out 
of 94 patients with blood COVID-19 antibodies 
tested during a follow-up study reported an 
initial seropositivity rate of 96·2% which later 
declined to 58·5% after 6 months. Likewise, 
the median titres of the neutralising antibodies 
dropped from 19·0 in the acute phase to 10·0 
after 180 days.  This is likely to be the reason 
for reported incidence of reinfection in patients 
after 5-6 months seen in some previously 
infected COVID-19 patients worldwide. 
Discussion 
 The long-term safety data on the 
COVID-19 vaccine is not available at the 
moment. Readers and users of the vaccines 
may rely on the great knowledge and 
advances that have materialized in the field of 
science and on the vaccine platforms. Credits 
go to remarkable and resilient Moderna rese- 
archers such as Kanika Karikó in collaboration 
with Weissman and in the UK, Professor Sarah 
Gilbert, the brainchild of AstraZeneca Oxford 
Vaccine.     
 From 8 days after receiving the 1st 
shot to ten weeks post 2nd dose vaccination, 
scientists would be eager to know whether 
initial immune response has been conferred, 
and studies are on ongoing on the Pfizer 
vaccine in Israel to answer these questions. In 
the coming months further down the lane, 
Immunologists are expected to perform 
complex T-cell tests to study T-cell memory 
vaccine-generated response to the spike 
proteins and how long lived the B-cell antibody 
production to these vaccine-induced spike 
proteins would be. It is expected that if 
individuals previously vaccinated become 
infected with SARS-COV-2, the effect would 
only be a mild or asymptomatic course of 
COVID-19 disease.   
 Scientists would also want to know 
whether sufficient anti–nucleocapsid IgG anti- 
body and anti-coronavirus spike antibody 
titres produced in response to the vaccination 
are sustainable long enough to get a patient 
through the long pandemic haul. It is at the 
moment uncertain if several multiple doses 
would be needed at intervals to build a 
sustained immunity.   
 The news of the expedited clinical 
trials of Oxford/AstraZeneca vaccine which 
began in April 2020 and approved for clinical 
patient use by 30th of December 2020 is refre- 
shing in the space of life sciences in the UK. 
The approval granted though quick did not 
sacrifice the integrity and safety of the vaccine 
science. Furthermore, everything about the 
Oxford vaccine is a plus; the cost, storage, UK-
made, and 100 million doses available for the 
UK population. The question now is how long 
before the herd immunity becomes a reality all 
over the world.  
Vaccine distribution, availability 
and storage issues 
 Beyond hoarding toilet paper in 2020 
is the challenge of effective and safe storage 
for vaccine in 2021 worldwide. Recommended 
temperature for Pfizer BioNTech vaccines is       
-80oC, while the Moderna vaccines is -20oC. 
Distribution and safe storage conditions are 
expected to be the major obstacles in Africa, 
South America, and South East Asia. 
Conclusions: 
 The world has suffered a significant 
amount of physical, emotional, and financial 
losses from dealing with the unforeseen 
challenges of COVID-19. At the time of writing 
this article, more than 84 million confirmed 
cases with close to 1.84 million deaths have 
been recorded worldwide as at 3rd of January 
2020 (20). A review of echocardiograms of 
1,261 patients from 69 countries by rese- 
archers at Edinburgh University revealed 
abnormal scans for more than half of hospi- 
talized COVID-19 patients; 55% of the 
patients in the study had abnormality in the 
pumping function of the heart, with one in 
seven showing evidence of severe dysfunction 
(21). Another study showed that 29.4% of 
47,780 COVID-19 patients who needed 
inpatient hospital treatment were readmitted 
within 140 days after the initial discharge 
home, with one in ten (12.3%) during the 
readmission being elderly (over 65 years of 
age), and Black, Asian and Minority Ethnic 
(BAME) backgrounds had the highest re-
admission rates (22). These data attest to the 
devastating cardiovascular effects of COVID-
19 among the BAME elderly and the need for 
an immediate use of vaccination for rescue.
 With the arrival of Pfizer, AstraZeneca, 
Moderna and other candidate vaccines, the 
uncertainties and questions around the world 
are; how long will the pandemic last? should I 
get the vaccines? what will our lives look like 




when the pandemic is over? could I still be 
infected post vaccination in the light of the fact 
that frontline health workers in the US and UK 
have been reported to develop severe COVID-
19, a month after receiving vaccination? 
Should this happen there is no need to panic, 
as it is estimated to take 8 days after 1st dose 
to 10 weeks of 2nd dose post vaccination for 
the much-desired immunity the vaccine 
confers to reach climax. Therefore, respon- 
sible citizens should continue with stringent 
measures to slow down the spread of SARS-
CoV-2, the virus that causes COVID-19. This 
means the wearing of facemasks, frequent 
handwashing, avoiding large gatherings or 
crowds and practicing social distancing. The 
take-home message is not rest on your oars 
despite the emergence of the new COVID-19 
vaccines.     
 This review is an attempt to address 
the doomsday conspiracy theories offered by 
poorly-informed social media anti-vaxxers 
who may have a large listening audience in 
less developed countries of the world. Anti-
vaccination has been around a long time, such 
as anti-fertility and anti-tetanus toxoid 
vaccines which have had severe impact on the 
willingness of people to take life-saving 
vaccines. There is therefore the need to 
debunk such outrageous claims and get the 
world in one voice to support scientists and 
researchers so that collectively we may 
retrace our footsteps and get our normal lives 
back. 
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